Vironix Health
Vironix Health and University of Oxford are conducting breakthrough research
Vironix Health and University of Oxford are conducting breakthrough research on using predictive models for early identification of patients who require…
Insights
Industry perspectives, clinical research, and updates from Vironix.
Vironix Health Secures New Capital Investors
Vironix successfully secured new capital commitments through a seed round extension convertible note at the prestigious Invest Wealth Summit 2023. Sumanth…
Vironix Health was pleased to attend the InFoMM Annual Meeting on June 23, at St. Catherine’s College, University of Oxford.
Vironix Health was pleased to attend the InFoMM (Industrially Focused Mathematical Modelling) Annual Meeting on June 23, at St. Catherine’s College,…
Vironix Health continues its work with students on machine learning models to predict chronic kidney disease stages with high accuracy.
Vironix Health: Predictive Modeling for Chronic Kidney Disease (CKD) Vironix was excited to continue its nearly 20-year involvement with students at the…
Vironix Health presents at ATS 2023
Shreyas Iyer presents on behalf of Vironix Health at the 2023 American Thoracic Society: Classifying Asthma Health Deterioration Using Synthetic Patient…
Vironix Health was selected to present at Innov8 Talks
Congratulations to the Vironix Health team members - Sumanth Swaminathan Botros Toro Ram Reddy and Jeff Hanson, MPH who presented their pitch at the 2023…